Menu

Bioluminescent Bacteria in a Wifi Pill Track Gut Health in Pigs

The micro-bio-electronic device combines bacteria that can detect certain molecules along with wifi-connected electrical outputs.

May 24, 2018
Kerry Grens

The ingestible biosensorLILLIE PAQUETTE, MITBioengineers have come up with a pill containing engineered bacteria and electronics that can read and wirelessly transmit information as a means of monitoring gut health. The prototype of this ingestible-micro-bio-electronic (IMBED) capsule was used to spot intestinal bleeding in pigs, the designers report today (May 24) in Science.

“We could evolve these living systems to conceivably sense any biological marker,” Mark Mimee, a graduate student at MIT and lead author of the study, tells STAT News.

The basic idea of Mimee’s pill is that bacteria glow in the presence of a particular molecule, and an adjacent electronic circuit detects the light signal and wirelessly transmits it to a cell phone. For this proof-of-concept demonstration, Mimee and his colleagues engineered E. coli to bioluminescence when they encounter the compound heme, an indicator of bleeding, in the guts of pigs. Packaged within a capsule 1.5 inches in length, the bacteria and electronics alerted the researchers to bleeding with the pigs’ guts within an hour of the pills being inserted with a tube, and kept transmitting data for two hours.

“A lot of important biology and health-related pathways are happening there, and we don’t have really good technologies to see inside the gut and measure chemicals there,” Jeff Tabor, a bioengineer at Rice University who was not involved in the study, tells STAT. “Getting the data back out is a challenge, so having a convenient, really practical strategy for having the bacteria tell us what they see is important.”

The researchers envision that such probiotic sensors could be developed to monitor the goings-on within organisms long-term, to pick up on multiple molecular signals simultaneously, and to be smaller.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.